Shots: The CHMP grants a positive opinion to Akantior for treating acanthamoeba keratitis based on the P-I & P-III studies. The final decision is anticipated in Aug 2024, to be valid across the EU incl. Iceland, Liechtenstein & Norway The P-I trial determined the effect of different polihexanide concentrations vs PBO among healthy individuals (n=90)…
